Vita Life Sciences Limited

Informe acción ASX:VLS

Capitalización de mercado: AU$116.1m

Salud financiera de hoja de balance de Vita Life Sciences

Salud financiera controles de criterios 6/6

Vita Life Sciences has a total shareholder equity of A$48.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$68.0M and A$19.3M respectively. Vita Life Sciences's EBIT is A$12.1M making its interest coverage ratio -13.1. It has cash and short-term investments of A$27.7M.

Información clave

0%

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses-13.1x
EfectivoAU$27.75m
PatrimonioAU$48.70m
Total pasivoAU$19.25m
Activos totalesAU$67.95m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 23
Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Aug 28
Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22
Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14
Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28
Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20
A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24
Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14
If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18
Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17
Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20
Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22
Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19
Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14
Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Análisis de la situación financiera

Pasivos a corto plazo: VLS's short term assets (A$56.3M) exceed its short term liabilities (A$19.0M).

Pasivo a largo plazo: VLS's short term assets (A$56.3M) exceed its long term liabilities (A$236.0K).


Historial y análisis de deuda-patrimonio

Nivel de deuda: VLS is debt free.

Reducción de la deuda: VLS has no debt compared to 5 years ago when its debt to equity ratio was 9%.

Cobertura de la deuda: VLS has no debt, therefore it does not need to be covered by operating cash flow.

Cobertura de intereses: VLS has no debt, therefore coverage of interest payments is not a concern.


Hoja de balance


Descubre empresas con salud financiera